insights_auto
Why is AVH up 4.03%?
Dive Deeperchevron_right
AVH:ASX
AVITA Medical Inc
A$3.87
arrow_upward
+4.03%(+0.15) 1D
Oct 16, 4:10:08 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVH...
Open
A$3.81
High
A$3.91
Low
A$3.81
Mkt. cap
604.79M
Avg. vol.
316.86K
Volume
527.45K
52-wk high
A$3.91
52-wk low
A$1.00
Shares outstanding
30.93M
No. of employees
226
Open
A$3.81
High
A$3.91
Low
A$3.81
Mkt. cap
604.79M
Avg. vol.
316.86K
Volume
527.45K
52-wk high
A$3.91
52-wk low
A$1.00
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
Moomoo
·
39 minutes ago
A Tick in the MarketWeek of October 12–16, 2026 — The AI hangover edition
Simply Wall Street
·
30 minutes ago
AI Platform Upgrade Might Change The Case For GitLab Stock
MarketBeat
·
38 minutes ago
HealthEquity, Inc. (NASDAQ:HQY) Stock Rated "Moderate Buy" by Wall Street Analysts
Yahoo Finance
·
3 hours ago
Wall Street’s record breakouts unravel as investors dump recent winners: Chart of the Day
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com